APA (7th ed.) Citation

Yuliya Lytvyn, Asfandyar Mufti, Abrahim Abduelmula, Muskaan Sachdeva, Khalad Maliyar, Jorge R. Georgakopoulos, & Jensen Yeung. (2022). Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review. MDPI AG.

Chicago Style (17th ed.) Citation

Yuliya Lytvyn, Asfandyar Mufti, Abrahim Abduelmula, Muskaan Sachdeva, Khalad Maliyar, Jorge R. Georgakopoulos, and Jensen Yeung. Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review. MDPI AG, 2022.

MLA (9th ed.) Citation

Yuliya Lytvyn, et al. Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review. MDPI AG, 2022.